Back to Journals » Drug Design, Development and Therapy » Volume 10

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

Total article views   HTML views PDF downloads Totals
14,575 Dovepress* 12,594+ 1,378 13,972
PubMed Central* 1,981 557 2,538
Totals 14,575 1,935 16,510
*Since 30 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
19 1 0 0 7 11

View citations on PubMed Central and Google Scholar